Experience

• 

  University of North Carolina at Charlotte

  • Charlotte, North Carolina Area

  • Assistatn Professor

    • Jan 2019 - Present
    • Charlotte, North Carolina Area

• 

  National University of Singapore

  • Singapore

  • Head of Neuro-Chip Program

    • Aug 2014 - Aug 2018
    • Singapore

    Head of Neuro-Chip program at SINAPSE in National University of Singapore. SINAPSE where I lead a Neuro-Chip program, comprising neurobiology teams, biomaterial teams, microfluidic teams, and bioelectronics teams. Neuro-Chip program is formed to discover novel medicines for 3D organoid/brain models to identify neuroprotective drugs, Axonal injuries (Chemotherapy induced Peripheral Neuropthy), Neuromuscular Junction models for ALS and SMA, and Myelination of axons by Oligodendrocytes and Schwann cells, Stem Cell therapies using neuroscience, microfluidics, and bioelectronics. My responsibilities include:1. Leadership of multidisciplinary and international research teams. 2. Responsible for strategic organisation and scientific management of Neuro-Chip program and neuroscience comprising in vitro and in vivo validation drug with novel biomedical Devices. 3. Performance management, compensation reviews, recruitment, and resource and budget management4. Research Collaborations with pharmaceutical companies drug development (e.g GSK) and 7 academic research institutions. 5. Lead the drug screening for Peripheal Neuropathies, axon injuries, and demyelination. 6. Develop biomedical devices for Neuroscience and drug discovery7. Direct Microfabrication facilities and neuroscience labs.

• 

  Johns Hopkins University

  • Faculty

    • Sep 2009 - Mar 2018

    Direct and manage research grants and activities as a Principal Investigator. Idea Awardee: Department of Defense. 2011 Concept Awardee: Department of Defense. 20111. Principal investigator of 2 grants funded by Department of Defense. Co-PI of 3 grants funded by Maryland Stem Cell Research Fund. 2. 5 neuroprotective drugs were identified by HTS for Chemotherapy Induced Peripheral Neuropathy. 3. Develop novel microfluidic devices for neuroscience research and drug screening. 4. Lead the drug screening for neurodegenerative diseases (Peripheral Neuropathies, axon injuries, ALS, and demyelination). 5. Leadership of multidisciplinary and international research teams.